SGRY logo

SGRY

Surgery Partners Inc.

$22.69
-$0.03(-0.13%)
54
Overall
--
Value
40
Tech
68
Quality
Market Cap
$2.91B
Volume
1.13M
52W Range
$18.87 - $33.90
Target Price
$31.00
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$959.9M$1.1B$592.6M$1.8B$1.8B$1.9B$2.2B$2.5B$2.7B$3.1B
Total Revenue
$959.9M$1.1B$592.6M$1.8B$1.8B$1.9B$2.2B$2.5B$2.7B$3.1B
COST OF GOODS SOLD
Cost of Revenue
$-669.3M$-821.2M$-441.6M$-1.4B$1.4B$1.5B$1.7B$2.0B$2.1B$2.4B
GROSS PROFIT
Gross Profit
$959.9M$1.1B$441.6M$-31.8M$1.8B$379.8M$491.4M$574.9M$2.7B$3.1B
OPERATING EXPENSES
Operating Expenses
$-815.1M$-949.0M$504.9M$-1.7B$1.6B$1.7B$1.9B$214.6M$2.4B$2.8B
Research & Development
----$26.0M--------------
Research Expense
----$26.0M--------------
Selling, General & Administrative
$409.5M$462.8M$263.1M$816.1M$787.0M$826.9M$970.4M$1.1B$1.2B$1.3B
Selling & Marketing Expenses
--------$543.6M$538.4M$636.4M$709.7M$745.0M$812.9M
General & Administrative Expenses
$409.5M$462.8M$263.1M$816.1M$243.4M$288.5M$334.0M$371.4M$417.7M$495.8M
Salaries & Wages
$261.7M$357.2M$175.4M$534.7M$550.0M$550.3M$644.3M$746.4M$793.8M$907.5M
Depreciation & Amortization
$34.5M$39.6M$21.8M$67.4M$76.5M$94.8M$98.8M$114.8M$118.1M$152.6M
Depreciation & Amortization
$34.5M$39.6M$21.8M$67.4M$76.5M$94.8M$98.8M$114.8M$118.1M$152.6M
Amortization
$-9.1M$-9.6M$-1.8M$-4.9M$3.4B$3.5B$3.9B$4.2B$2.9M$46.9M
Other Operating Expenses
$81.8M$85.3M$44.6M$104.2M$28.1M$65.9M$77.5M$156.7M$175.3M$201.7M
OPERATING INCOME
Operating income
$172.4M$200.6M$-504.9M$-1.6B$235.9M$183.0M$302.2M$345.2M$328.0M$348.8M
EBITDA
$84.2M$142.2M$40.4M$-1.8M$273.2M$277.8M$401.0M$460.0M$301.7M$361.5M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--------$13.0M$201.8M$221.0M$234.9M$48.6M$61.8M
Intinc
$-101.0M$-100.6M$-48.7M$-147.0M$-178.9M$-201.8M$-221.0M$-234.9M$-193.0M$-201.7M
Net Non-Operating Interest Income/Expense
$-101.0M$-100.6M$-48.7M$-147.0M$-178.9M$-201.8M$-221.0M$-234.9M$-193.0M$-201.7M
Gain on Sale of Securities
------$1.1M------------
Other Income/Expense
$28.1M$18.2M$-589.6M$-1.7B$20.5M$12.4M$37.6M$-15.1M$63.0M$85.7M
Other Special Charges
$-16.1M$-11.9M$592.6M$1.8B$-11.7M--$-9.1M$-14.9M$-15.5M$-5.1M
SPECIAL ITEMS
Special Income Charges
$525.0K$14.0M$8.7M$-116.7M$-6.7M$-72.5M$15.5M$45.9M$-3.1M$20.8M
Impairment of Capital Assets
------$74.4M$7.9M$33.5M--------
PRE-TAX INCOME
EBIT
$43.8M$95.9M$18.6M$-69.2M$196.7M$183.0M$302.2M$345.2M$183.6M$208.9M
Pre-Tax Income
$43.8M$95.9M$18.6M$-69.2M$183.7M$35.5M$180.7M$110.3M$234.3M$147.1M
INCOME TAX
Tax Provision
$-29.1M$10.8M$46.3M$26.4M$11.9M$-20.1M$10.5M$23.3M$-300.0K$134.6M
NET INCOME
Net Income
$1.4M$9.5M$-67.4M$-238.1M$-74.8M$-116.1M$-70.9M$-54.6M$-11.9M$-168.1M
Net Income (Continuing Operations)
$1.4M$9.5M$-67.4M$-238.1M$-74.8M$-116.1M$-70.9M$87.0M$135.3M$12.5M
Net Income (Discontinued Operations)
$1.4M$9.5M$-67.4M$-238.1M$-74.8M$-116.1M$-70.9M$-54.6M$-11.9M$-168.1M
Net Income (Common Stockholders)
$1.4M$9.5M$-67.4M$-238.1M$-110.5M$-155.6M$-81.2M$-54.6M$-11.9M$-168.1M
Normalized Income
------------------$353.7M
TOTALS
Total Expenses
$-1.5B$-1.8B$63.3M$-3.1B$1.6B$1.7B$1.9B$2.2B$2.4B$2.8B
SHARE & EPS DATA
Average Shares Outstanding
$36.1M$48.0M$48.3M$48.0M$48.3M$48.8M$72.4M$92.0M$125.6M$126.1M
Average Shares Outstanding (Diluted)
$37.5M$48.2M$48.3M$48.0M$48.3M--$72.4M$92.0M$125.6M$126.1M
Shares Outstanding
$48.2M$48.6M$48.6M$48.8M$49.3M$59.9M$89.4M$126.0M$126.6M$127.6M
Basic EPS
$0.04$0.20$-1.39$-3.25$-2.29$-3.19$-1.12$-0.59$-0.09$-1.33
Basic EPS (Continuing Operations)
--------$-2.29$-3.19$-1.12$-0.59$-0.09$-1.33
Diluted EPS
$0.04$0.20$-1.39$-4.96$-2.29$-3.19$-1.12$-0.59$-0.09$-1.33
Diluted EPS (Continuing Operations)
------------$-1.12$-0.59$-0.09$-1.33
OTHER METRICS
Accretion On Preferred Stock
----$-32.4M$-32.4M----$439.7M------
Accrued Preferred Stock Dividends
----$-9.2M$-33.8M$-69.5M$-39.5M$-10.3M------
Acquisition Expense
--------$2.8M$6.6M$6.3M$1.1M$3.2M--
Earnings from equity interest
$3.8M$4.8M$3.3M$8.9M$10.2M$10.8M$11.3M$12.5M$14.2M$19.5M
Earnings From Equity Interest Net Of Tax
$3.8M$4.8M$3.3M$8.9M$10.2M$10.8M$11.3M$12.5M$14.2M$19.5M
Gain On Sale Of Business
----$800.0K--------------
Gain On Sale Of P P E
$2.1M$-2.4M$-5.0K$-31.8M------------
Interest Expense Operating
----$1.9M--------------
Loss And Loss Adjustment Expected Incurred
----$26.0M------$10.3M------
Minority Interests
$-71.4M$-75.6M$-39.6M$-110.1M$-119.9M$-117.4M$-141.6M$-141.6M$-147.2M$-180.6M
Non Recurring Operation Expense
$-525.0K$-14.0M$-8.7M$42.3M$-1.2M$39.0M$-15.5M$-45.9M$3.1M$-20.8M
Other Gand A
$409.5M$462.8M$263.1M$816.1M$243.4M$288.5M$334.0M$371.4M$417.7M$495.8M
Other Impairment Of Capital Assets
------$-74.4M$2.5M$33.5M--------
Other Write Down
--------$35.7M----------
Other Write Off
$-10.6M$-12.7M$-10.4M--------------
Otherunder Preferred Stock Dividend
----$-32.4M$-66.2M$-69.5M$-39.5M$429.4M------
Preferred Stock Dividends
----$-32.4M$-66.2M$-69.5M$-39.5M$429.4M------
Realized Capital Gain
----$1.1M--------------
Rent And Landing Fees
$100.8M$112.4M$57.0M$180.3M$85.6M----------
Selling Expense
--------$35.7M----------
Write Down
$-8.4M$-552.0K----------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2SGRY$22.69-0.1%1.13M
3
4
5
6

Get Surgery Partners Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.